Market Research Reports

Gathering genetic codes - Prader Willi Syndrome (PWS) The latest Pharmaceutical and  Healthcare  disease pipeline guide  Prader-Willi Syndrome Market , provides an overview of the Prader-Willi Syndrome (PWS) pipeline landscape. Symptoms include: - Poor muscle tone - Low levels of sex hormones - A constant feeling of hunger.  Key Highlights: - Prader-Willi Syndrome (PWS) - Complete with analysis by stage of development - Drug target - Mechanism of action (MoA) - Route of administration (RoA) - Molecule type. Key Players: - C overs therapeutics under Development by Companies /Universities /Institutes - The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are 7, 6, 8, 5 and 12 respectively - The Universities portfolio in Preclinical stages comprises 1 molecules, respectively. Emerging Players: - Proprietary databases - Company/university websites - Clinical t...

Treating cancer induced Neutropenia The latest Pharmaceutical and  Healthcare  disease pipeline guide  Chemotherapy Induced Neutropenia Market , provides an overview of the Chemotherapy Induced Neutropenia (Toxicology) pipeline landscape. Symptoms include: - Severe fatigue - Weakness - Anxiety - Lack of energy - Shortness of breath - Headaches - Pale appearance - Rapid heart rate or palpitations - Chest pain dizziness - Abdominal pain. Key Highlights: - Chemotherapy Induced Neutropenia (Toxicology) - Complete with analysis by stage of development - Drug target - Mechanism of action (MoA) - Route of administration (RoA) - Molecule type. Key Players: - C overs therapeutics under Development by Companies /Universities /Institutes - The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are 7, 6, 8, 5 and 12 respectively - The Universities portfolio in Preclinical stages ...

Country Healthcare Landscape Market Report - Austria The Country Healthcare Landscape Market report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Austria. Report Forecast The value of the Austrian pharmaceutical market declined from $3.30 billion in 2010 to $3.23 billion in 2016, at a negative compound annual growth rate (CAGR) of 0.33%. However, in terms of Euro, the market value increased from €2.48 billion in 2010 to €2.87 billion in 2017, at a CAGR of 2%. The decline in the market value in Euro terms was driven by the fluctuations in the exchange rate of the Euro versus the US dollar and increased consumption of generics. The Austrian medical device market was valued at $1.63 billion in 2010 and increased to $1.95 billion i...